timolol has been researched along with Retinal Vein Occlusion in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, A; Ehmann, D; Gao, X; Ho, AC; Hsu, J; Obeid, A; Park, CH; Sridhar, J | 1 |
Hardarson, SH | 1 |
Byeon, SH; Kim, SE; Kwon, OW; Park, YS; Song, JH | 1 |
Gupta, V; Sihota, R; Sony, P | 1 |
Townsend-Pico, W; Yoshizumi, MO | 1 |
1 trial(s) available for timolol and Retinal Vein Occlusion
Article | Year |
---|---|
Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide).
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Aqueous Humor; Bevacizumab; Diabetic Retinopathy; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Visual Acuity; Vitreous Body | 2009 |
4 other study(ies) available for timolol and Retinal Vein Occlusion
Article | Year |
---|---|
TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Drug Combinations; Drug Therapy, Combination; Female; Fovea Centralis; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2021 |
Retinal oximetry.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Case-Control Studies; Dark Adaptation; Diabetic Retinopathy; Drug Combinations; Female; Glaucoma; Humans; Light; Male; Middle Aged; Oximetry; Oxygen; Regional Blood Flow; Retinal Artery Occlusion; Retinal Vein Occlusion; Retinal Vessels; Sulfonamides; Thiophenes; Timolol; Young Adult | 2013 |
Bilateral retinal venous occlusion in pigmentary glaucoma.
Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Exfoliation Syndrome; Functional Laterality; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Quinoxalines; Retinal Vein Occlusion; Timolol; Trabecular Meshwork; Vision Disorders; Visual Field Tests; Visual Fields | 2005 |
Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma.
Topics: Adrenergic beta-Antagonists; Antisickling Agents; Aspirin; Bone Marrow; Fluorescein Angiography; Fundus Oculi; Glaucoma, Neovascular; Humans; Hydroxyurea; Intraocular Pressure; Laser Coagulation; Male; Middle Aged; Neovascularization, Pathologic; Optic Disk; Platelet Aggregation Inhibitors; Platelet Count; Retinal Vein Occlusion; Thrombocythemia, Essential; Timolol | 1996 |